Hyperhomocysteinemia as a risk factor for venous thrombosis (Q34395800)

1 August 2017

1 reference

title

Hyperhomocysteinemia as a risk factor for venous thrombosis (English)

1 reference

1 August 2017

0 references

0 references

M den Heijer

1

1 reference

PubMed ID

11592438

1 August 2017

M B Keijzer

series ordinal

2

1 reference

1 August 2017

1 August 2001

1 reference

Clinical Chemistry and Laboratory Medicine

1 August 2017

1 reference

1 August 2017

39

1 reference

1 August 2017

8

1 reference

1 August 2017

710-713

1 reference

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

1 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.117

21 January 2018

Identifiers

DOI

10.1515/CCLM.2001.117

1 reference

1 August 2017

1 reference

PubMed ID

11592438